3:49 PM
 | 
May 16, 2018
 |  BC Extra  |  Financial News

Report: Seidenberg to start new firm

Kleiner Perkins Caufield & Byers’ Beth Seidenberg is raising money to start her own life sciences investment firm, according to a report published by Recode, which did not cite its source. Kleiner Perkins said Seidenberg remains a partner at the firm.

"Beth remains an investing partner with the firm to manage her investments and she will continue to serve on the boards of directors of companies where she is the lead partner for Kleiner Perkins," the firm said in a statement.

The firm did not respond to follow up questions regarding Seidenberg’s plans to start her own venture, and Seidenberg did not respond to inquiries in time for publication.

Seidenberg joined KPCB in 2005 and has since incubated eight companies and served as the founding CEO of two. She serves on the board of multiple Kleiner Perkins portfolio companies, including cancer company Armo Sciences Inc. (NASDAQ:ARMO). Last week, Eli Lilly and Co. (NYSE:LLY) said it would purchase Armo for about $1.6 billion in cash (see BioCentury Extra, May 10).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD